Dibromidobis(1-ethyl-2,6-dimethyl­pyridinium-4-olate-κO)zinc(II)

In the bioactive title compound, [ZnBr(2)(C(9)H(13)NO)(2)], the Zn(II) atom is coordinated in a distorted tetra­hedral arrangement by two Br(−) anions and the O atoms of two zwitterionic organic ligands. The pyridinium rings are almost planar [maximum deviations = 0.004 (4) and 0.003 (4) Å]. The ethyl groups are approximately perpendicular to the corresponding pyridinium ring planes [N—C—C—C = 88.8 (4)° in each ligand]. The packing of the mol­ecules is controlled by π–π inter­actions, with centroid–centroid distances of 3.625 (3) and 3.711 (2) Å, forming chains approximately parallel to (102). The crystal studied was non-merohedrally twinned (twin relationship between the domains 1 0 0, 0 1 0, −0.4672 −0.1864 −1 and batch scale factor of 7.39%).